KR100361933B1
(ko)
*
|
1993-09-08 |
2003-02-14 |
라 졸라 파마슈티칼 컴파니 |
화학적으로정의된비중합성결합가플랫폼분자및그것의콘주게이트
|
AU1825299A
(en)
*
|
1997-12-17 |
1999-07-05 |
Enzon, Inc. |
Polymeric prodrugs of amino- and hydroxyl-containing bioactive agents
|
DK1121382T3
(da)
|
1998-10-16 |
2006-11-13 |
Biogen Idec Inc |
Interferon-beta-fusionsproteiner og deres anvendelser
|
PT1121156E
(pt)
*
|
1998-10-16 |
2006-05-31 |
Biogen Idec Inc |
Conjugados de polimeros de interferao-beta-1a e as suas utilizacoes
|
US6458953B1
(en)
*
|
1998-12-09 |
2002-10-01 |
La Jolla Pharmaceutical Company |
Valency platform molecules comprising carbamate linkages
|
US7303760B2
(en)
*
|
1999-04-23 |
2007-12-04 |
Alza Corporation |
Method for treating multi-drug resistant tumors
|
DE60030965T2
(de)
*
|
1999-04-23 |
2007-05-24 |
Alza Corp., Mountain View |
Konjugate enthaltend eine spaltbare bindung zur anwendung in einem liposom
|
US7238368B2
(en)
*
|
1999-04-23 |
2007-07-03 |
Alza Corporation |
Releasable linkage and compositions containing same
|
US6713454B1
(en)
|
1999-09-13 |
2004-03-30 |
Nobex Corporation |
Prodrugs of etoposide and etoposide analogs
|
CA2412162A1
(en)
*
|
2000-07-12 |
2002-01-17 |
Gryphon Therapeutics, Inc. |
Chemokine receptor modulators, production and use
|
US7118737B2
(en)
|
2000-09-08 |
2006-10-10 |
Amylin Pharmaceuticals, Inc. |
Polymer-modified synthetic proteins
|
EE200300089A
(et)
*
|
2000-09-08 |
2005-02-15 |
Gryphon Therapeutics, Inc. |
Sünteetilised erütropoeesi stimuleerivad valgud, nende valmistamismeetodid ning kasutamine
|
WO2002066066A1
(en)
*
|
2001-02-20 |
2002-08-29 |
Enzon, Inc. |
Terminally-branched polymeric linkers and polymeric conjugates containing the same
|
EP1379257B1
(de)
*
|
2001-03-23 |
2009-08-12 |
Enzon, Inc. |
Prodrugs von krebsmitteln mit substituierten aromatischen säuren
|
US20040077835A1
(en)
*
|
2001-07-12 |
2004-04-22 |
Robin Offord |
Chemokine receptor modulators, production and use
|
CN101700401B
(zh)
*
|
2002-01-18 |
2013-08-14 |
比奥根艾迪克Ma公司 |
具有用于共轭生物活性化合物的部分的聚亚烷基二醇
|
AU2003253890A1
(en)
*
|
2002-07-12 |
2004-02-02 |
Biomarin Pharmaceutical Inc. |
The use of isocyanate linkers to make hydrolyzable active agent biopolymer conjugates
|
US20040062748A1
(en)
*
|
2002-09-30 |
2004-04-01 |
Mountain View Pharmaceuticals, Inc. |
Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof
|
US8129330B2
(en)
|
2002-09-30 |
2012-03-06 |
Mountain View Pharmaceuticals, Inc. |
Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof
|
US20040152769A1
(en)
*
|
2002-11-09 |
2004-08-05 |
Ekwuribe Nnochiri Nkem |
Modified carbamate-containing prodrugs and methods of synthesizing same
|
AU2003295432A1
(en)
*
|
2002-11-12 |
2004-06-03 |
Enzon Pharmaceuticals, Inc. |
Prodrugs of vancomycin with hydrolysis resistant polymer linkers
|
US8034900B2
(en)
*
|
2002-12-30 |
2011-10-11 |
Amylin Pharmaceuticals, Inc. |
Water-soluble thioester and selenoester compounds and methods for making and using the same
|
EP1597299A2
(de)
*
|
2003-02-19 |
2005-11-23 |
Pharmacia Corporation |
Mit oxalatestern aktivierte carbonatester von polyethylenglykol
|
US7332164B2
(en)
*
|
2003-03-21 |
2008-02-19 |
Enzon Pharmaceuticals, Inc. |
Heterobifunctional polymeric bioconjugates
|
NZ542687A
(en)
*
|
2003-04-13 |
2010-02-26 |
Enzon Pharmaceuticals Inc |
Polymeric oligonucleotide prodrugs
|
US20050249697A1
(en)
*
|
2003-09-24 |
2005-11-10 |
Uhrich Kathryn E |
Compositions and methods for the inhibition of bone growth and resorption
|
WO2005067644A2
(en)
*
|
2004-01-07 |
2005-07-28 |
Ambit Biosciences Corporation |
Conjugated small molecules
|
EP1807436B1
(de)
*
|
2004-10-25 |
2014-06-18 |
Intezyne Technologies Inc. |
Heterobifunktionelles poly(ethylenglykol) und seine verwendungen
|
WO2006105993A2
(en)
|
2005-04-05 |
2006-10-12 |
Istituto Di Ricerche Di Biologia Molecolare P Angeletti Spa |
Method for shielding functional sites or epitopes on proteins
|
US20070185135A1
(en)
*
|
2005-12-30 |
2007-08-09 |
Pharmaessentia Corp. |
Drug-Polymer Conjugates
|
GB0604187D0
(en)
*
|
2006-03-02 |
2006-04-12 |
Fusion Antibodies Ltd |
Peptide and uses thereof
|
CA2861601A1
(en)
|
2006-04-27 |
2007-11-08 |
Intezyne Technologies, Inc. |
Poly (ethylene glycol) containing chemically disparate endgroups
|
AU2007248680C1
(en)
|
2006-05-02 |
2014-01-23 |
Allozyne, Inc. |
Non-natural amino acid substituted polypeptides
|
US20080096819A1
(en)
*
|
2006-05-02 |
2008-04-24 |
Allozyne, Inc. |
Amino acid substituted molecules
|
GB0611405D0
(en)
*
|
2006-06-09 |
2006-07-19 |
Univ Belfast |
FKBP-L: A novel inhibitor of angiogenesis
|
US20090156629A1
(en)
*
|
2006-06-09 |
2009-06-18 |
Enzon Pharmaceuticals, Inc. |
Indenoisoquinoline-releasable polymer conjugates
|
WO2008011234A2
(en)
*
|
2006-06-30 |
2008-01-24 |
Enzon Pharmaceuticals, Inc. |
Recombinant host for producing l-asparaginase ii
|
AU2007296055A1
(en)
*
|
2006-09-15 |
2008-03-20 |
Enzon Pharmaceuticals, Inc. |
Polymeric conjugates containing positively-charged moieties
|
US7985783B2
(en)
|
2006-09-21 |
2011-07-26 |
The Regents Of The University Of California |
Aldehyde tags, uses thereof in site-specific protein modification
|
CA2664271A1
(en)
*
|
2006-11-27 |
2008-06-12 |
Enzon Pharmaceuticals, Inc. |
Polymeric short interfering rna conjugates
|
TW200835514A
(en)
*
|
2006-12-29 |
2008-09-01 |
Enzon Pharmaceuticals Inc |
Use of adenosine deaminase for treating pulmonary disease
|
ES2569940T3
(es)
|
2007-04-20 |
2016-05-13 |
Sigma-Tau Rare Disease Ltd |
Adenosina desaminasa recombinante estable
|
ES2507508T3
(es)
*
|
2007-04-20 |
2014-10-15 |
Sigma-Tau Rare Diseases S.A. |
Terapia anticancerígena enzimática
|
CA2693616A1
(en)
*
|
2007-07-11 |
2009-01-15 |
Enzon Pharmaceuticals, Inc. |
Polymeric drug delivery system containing a multi-substituted aromatic moiety
|
JP2010533233A
(ja)
*
|
2007-07-11 |
2010-10-21 |
エンゾン ファーマシューティカルズ,インコーポレーテッド |
芳香族アリル酸を含むポリマー性薬剤送達システム
|
CA2707840A1
(en)
|
2007-08-20 |
2009-02-26 |
Allozyne, Inc. |
Amino acid substituted molecules
|
EP2445343B1
(de)
|
2009-06-25 |
2021-08-04 |
Alkermes Pharma Ireland Limited |
Prodrugs aus nh-säureverbindungen
|
SI2445502T1
(sl)
|
2009-06-25 |
2017-10-30 |
Alkermes Pharma Ireland Limited |
Heterociklične spojine za zdravljenje neuroloških in psiholoških motenj
|
WO2011084851A1
(en)
*
|
2010-01-07 |
2011-07-14 |
Alkermes, Inc. |
Asenapine produrugs
|
US20110166156A1
(en)
*
|
2010-01-07 |
2011-07-07 |
Alkermes, Inc. |
Prodrugs for the Treatment of Schizophrenia and Bipolar Disease
|
CA2804034C
(en)
|
2010-01-07 |
2016-12-13 |
Laura Cook Blumberg |
Prodrugs of heteraromatic compounds
|
WO2011084849A1
(en)
*
|
2010-01-07 |
2011-07-14 |
Alkermes, Inc. |
Diaryldiazepine prodrugs for the treatment of neurological and psychological disorders
|
ES2647361T3
(es)
*
|
2010-01-07 |
2017-12-21 |
Alkermes Pharma Ireland Limited |
Profármacos de sales de amonio cuaternario
|
WO2011163594A2
(en)
|
2010-06-24 |
2011-12-29 |
Alkermes, Inc. |
Prodrugs of nh-acidic compounds: ester, carbonate, carbamate and phosphonate derivatives
|
AU2011325990C1
(en)
|
2010-11-12 |
2017-06-08 |
Nektar Therapeutics |
Conjugates of an IL-2 moiety and a polymer
|
US8846941B2
(en)
|
2010-12-13 |
2014-09-30 |
Quiapeg Ab |
Functionalized polymers
|
JP5941926B2
(ja)
*
|
2010-12-29 |
2016-06-29 |
アローヘッド リサーチ コーポレイション |
酵素感受性連結を有するインビボポリヌクレオチド送達結合体
|
LT2685979T
(lt)
|
2011-03-18 |
2016-12-12 |
Alkermes Pharma Ireland Limited |
Injekcinės farmacinės kompozicijos, apimančios vandenyje netirpų antipsichotiką, sorbitano lauratą ir polisorbatą 20
|
DE102011118029A1
(de)
|
2011-06-20 |
2012-12-20 |
Universität Leipzig |
Modifizierte antibiotische Peptide mit variabler systemischer Freisetzung
|
JP6208658B2
(ja)
|
2011-07-05 |
2017-10-04 |
バイオアシス テクノロジーズ インコーポレイテッド |
p97−抗体結合体および使用方法
|
AU2012351747B2
(en)
|
2011-12-15 |
2016-05-12 |
Alkermes Pharma Ireland Limited |
Prodrugs of secondary amine compounds
|
NZ630643A
(en)
|
2012-03-19 |
2017-08-25 |
Alkermes Pharma Ireland Ltd |
Pharmaceutical compositions comprising fatty acid esters
|
CA2867123C
(en)
|
2012-03-19 |
2021-02-16 |
Alkermes Pharma Ireland Limited |
Pharmaceutical compositions comprising water-insoluble antipsychotic agents and glycerol esters
|
EP2827866B1
(de)
|
2012-03-19 |
2023-05-03 |
Alkermes Pharma Ireland Limited |
Pharmazeutische zusammensetzungen mit benzylalkohol
|
CA2876315C
(en)
|
2012-06-12 |
2021-05-25 |
Marek Kwiatkowski |
Conjugates of biologically active molecules to functionalized polymers
|
CA3140358A1
(en)
|
2012-07-31 |
2014-02-06 |
Bioasis Technologies, Inc. |
Dephosphorylated lysosomal storage disease proteins and methods of use thereof
|
EP2897592B1
(de)
|
2012-09-19 |
2020-02-19 |
Alkermes Pharma Ireland Limited |
Pharmazeutische zusammensetzungen mit verbesserter lagerstabilität
|
US9605078B2
(en)
|
2012-11-16 |
2017-03-28 |
The Regents Of The University Of California |
Pictet-Spengler ligation for protein chemical modification
|
US9310374B2
(en)
|
2012-11-16 |
2016-04-12 |
Redwood Bioscience, Inc. |
Hydrazinyl-indole compounds and methods for producing a conjugate
|
CA2906003C
(en)
|
2013-03-13 |
2021-07-06 |
Bioasis Technologies Inc. |
Fragments of p97 and uses thereof
|
EP3038657A2
(de)
|
2013-08-28 |
2016-07-06 |
Bioasis Technologies Inc. |
Cns-gerichtete konjugate mit modifizierten fc-regionen und verfahren zur verwendung davon
|
CN105744935B
(zh)
|
2013-11-27 |
2022-09-30 |
雷德伍德生物科技股份有限公司 |
肼基-吡咯并化合物及用于生成缀合物的方法
|
CN107073119A
(zh)
|
2014-02-26 |
2017-08-18 |
德克萨斯大学系统董事会 |
用于操控细胞酸中毒的硝基苯甲醛质子的释放
|
RU2688233C2
(ru)
|
2014-03-20 |
2019-05-21 |
Алкермес Фарма Айэленд Лимитед |
Препараты арипипразола, имеющие повышенные скорости впрыска
|
DK3207130T3
(da)
|
2014-10-14 |
2019-11-11 |
Halozyme Inc |
Sammensætninger af Adenosin Deaminase-2 (ADA2), varianter deraf og fremgangsmåder til anvendelse af samme
|
JP7109427B2
(ja)
|
2016-06-01 |
2022-07-29 |
セルヴィエ アイピー ユーケー リミテッド |
ポリアルキレンオキシド-アスパラギナーゼの製剤ならびにその製造法および使用法
|
KR102345175B1
(ko)
|
2016-11-14 |
2021-12-31 |
항저우 디에이씨 바이오테크 씨오, 엘티디 |
결합 링커, 그러한 결합 링커를 함유하는 세포 결합 분자-약물 결합체, 링커를 갖는 그러한 결합체의 제조 및 사용
|
CN108727208B
(zh)
*
|
2017-03-07 |
2020-06-30 |
天津键凯科技有限公司 |
一种连接子化合物、聚乙二醇-连接子结合物及其衍生物和聚乙二醇-连接子-药物结合物
|
DK3592393T3
(da)
|
2017-03-10 |
2022-03-07 |
Quiapeg Pharmaceuticals Ab |
Frigørbare konjugater
|
JP7022328B2
(ja)
|
2017-03-30 |
2022-02-18 |
日油株式会社 |
自壊性アセタールリンカーを有する親水性ポリマー誘導体及びそれを用いた複合体
|
JP7338873B2
(ja)
|
2017-07-19 |
2023-09-05 |
ユニケリス・リミテッド |
強皮症関連血管障害を治療または改善するための組成物および方法
|
EP4257198A3
(de)
|
2017-08-22 |
2023-10-18 |
Dynavax Technologies Corporation |
Alkylkettenmodifizierte imidazochinolin-derivate als tlr7/8-agonisten und verwendungen davon
|
CN114668852A
(zh)
*
|
2017-09-30 |
2022-06-28 |
天津键凯科技有限公司 |
一种聚乙二醇-多肽和蛋白类药物的结合物
|
CN109589415B
(zh)
|
2017-09-30 |
2022-02-18 |
天津键凯科技有限公司 |
一种聚乙二醇-多肽和蛋白类药物的结合物
|
EP3710059A1
(de)
|
2017-11-14 |
2020-09-23 |
Dynavax Technologies Corporation |
Spaltbare konjugate von tlr7/8-agonist-verbindungen, verfahren zur herstellung und verwendungen davon
|
US11492493B2
(en)
|
2017-12-26 |
2022-11-08 |
Becton, Dickinson And Company |
Deep ultraviolet-excitable water-solvated polymeric dyes
|
CN112423754A
(zh)
|
2018-03-05 |
2021-02-26 |
奥克梅斯制药爱尔兰有限公司 |
阿立哌唑的给药策略
|
EP3775052B1
(de)
|
2018-03-30 |
2024-06-05 |
Becton, Dickinson and Company |
Wasserlösliche polymere farbstoffe mit seitenständigen chromophoren
|
WO2020023300A1
(en)
|
2018-07-22 |
2020-01-30 |
Bioasis Technologies, Inc. |
Treatment of lymmphatic metastases
|
BR112021004689A2
(pt)
|
2018-09-12 |
2021-06-08 |
Quiapeg Pharmaceuticals Ab |
conjugados glp-1 liberáveis
|
EP3909612A1
(de)
|
2020-05-12 |
2021-11-17 |
Life Science Inkubator Betriebs GmbH & Co. KG |
Zusammensetzung von nanopartikeln
|
US20210355468A1
(en)
|
2020-05-18 |
2021-11-18 |
Bioasis Technologies, Inc. |
Compositions and methods for treating lewy body dementia
|
US20210393787A1
(en)
|
2020-06-17 |
2021-12-23 |
Bioasis Technologies, Inc. |
Compositions and methods for treating frontotemporal dementia
|
EP3954393A1
(de)
|
2020-08-13 |
2022-02-16 |
Bioasis Technologies Inc. |
Kombinationstherapien zur verabreichung über die blut-hirn-schranke hinweg
|
EP4155349A1
(de)
|
2021-09-24 |
2023-03-29 |
Becton, Dickinson and Company |
Wasserlösliche gelbe grünabsorbierende farbstoffe
|
WO2024007016A2
(en)
|
2022-07-01 |
2024-01-04 |
Beckman Coulter, Inc. |
Novel fluorescent dyes and polymers from dihydrophenanthrene derivatives
|
WO2024044327A1
(en)
|
2022-08-26 |
2024-02-29 |
Beckman Coulter, Inc. |
Dhnt monomers and polymer dyes with modified photophysical properties
|